Katherine Anderson is CFO at REPROS THERAPEUTICS INC. (RPRX). They have made 7 open-market trades across 1 company since 2012, most recently 2018-01-29.
CIK 0001476301
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $139K since 2012, never a sale. Across 7 scored buys the stock is up 1.1% at ninety days, and 0.5 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RPRX | 83,875 | $5.1M |
Shares reported on the most recent Form 4, priced at the 2017-07-05 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +18.4% | +1.1% | +1.1% |
| Alpha | -36.0% | +0.7% | -0.5% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPRX | BUY | 2016-01-27 | 2016-01-28 | $1.08 | $13K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2014-11-12 | 2014-11-12 | $9.41 | $33K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2014-08-14 | 2014-08-14 | $13.85 | $28K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2013-10-25 | 2013-10-25 | $17.90 | $18K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2013-10-10 | 2013-10-11 | $23.77 | $24K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2013-02-01 | 2013-02-04 | $11.89 | $12K | +18.4% | +1.1% | +1.1% |
| RPRX | BUY | 2012-04-13 | 2012-04-16 | $3.86 | $12K | +18.4% | +1.1% | +1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.